SEC Form 4 · accession 0001127602-17-014419
LABCORP HOLDINGS INC. · LH
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
M. Huff Gary
Officer — CEO, LabCorp Diagnostics
Period of report
Apr 4, 2017
Accepted (ET)
Apr 6, 2017 · 9:55 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000920148
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock UnitF3,F1,F2 | — | Apr 4, 2017 | A | 1,890 | A | — | — | Common Stock | 1,890 | 3,690 | D |
| Restricted Stock UnitF3,F1,F4 | — | Apr 4, 2017 | A | 10,500 | A | — | — | Common Stock | 10,500 | 14,190 | D |
Explanation of responses
- F1Each restricted stock unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock.
- F2The Restricted Stock Units vest in three equal annual installments beginning on 2/7/18.
- F3This number reflects the aggregate number of Restricted Stock Units held by the reporting person.
- F4The Restricted Stock Units vest in three equal annual installments beginning on 4/4/18.